tradingkey.logo

Pacific Biosciences of California Inc

PACB

1.280USD

+0.050+4.07%
終値 09/18, 16:00ET15分遅れの株価
384.45M時価総額
損失額直近12ヶ月PER

Pacific Biosciences of California Inc

1.280

+0.050+4.07%
詳細情報 Pacific Biosciences of California Inc 企業名
Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
企業情報
企業コードPACB
会社名Pacific Biosciences of California Inc
上場日Oct 27, 2010
最高経営責任者「CEO」Mr. Christian O. Henry
従業員数575
証券種類Ordinary Share
決算期末Oct 27
本社所在地1305 O'brien Drive
都市MENLO PARK
証券取引所NASDAQ Global Select Consolidated
United States of America
郵便番号94025
電話番号16505218000
ウェブサイトhttps://www.pacb.com/
企業コードPACB
上場日Oct 27, 2010
最高経営責任者「CEO」Mr. Christian O. Henry
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
Dr. Lucy Shapiro, Ph.D.
Dr. Lucy Shapiro, Ph.D.
Independent Director
Independent Director
--
-100.00%
Mr. Mark Van Oene
Mr. Mark Van Oene
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jim R. Gibson
Mr. Jim R. Gibson
Chief Financial Officer, Principal Financial Officer
Chief Financial Officer, Principal Financial Officer
--
--
Ms. Kathy P. Ordonez
Ms. Kathy P. Ordonez
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Christian O. Henry
Mr. Christian O. Henry
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
696.81K
-17.96%
Mr. Marshall L. Mohr, CPA
Mr. Marshall L. Mohr, CPA
Independent Director
Independent Director
110.00K
-17.18%
Dr. John F. Milligan, Ph.D.
Dr. John F. Milligan, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
110.00K
-17.18%
Mr. Randall S. (Randy) Livingston
Mr. Randall S. (Randy) Livingston
Independent Director
Independent Director
22.82K
--
Dr. Hannah A. Valantine, M.D.
Dr. Hannah A. Valantine, M.D.
Independent Director
Independent Director
--
--
Mr. Christopher M. (Chris) Smith
Mr. Christopher M. (Chris) Smith
Independent Director
Independent Director
--
--
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
地域別USD
会社名
収益
比率
North America
16.30M
43.88%
Asia Pacific
11.61M
31.25%
Europe (including the Middle East and Africa)
9.24M
24.87%
事業別
地域別
事業別USD
会社名
収益
比率
Consumable revenue
20.10M
54.09%
Instrument revenue
11.02M
29.65%
Service And Other
6.04M
16.26%
株主
更新時刻: Tue, Sep 16
更新時刻: Tue, Sep 16
株主統計
種類
株主統計
株主統計
比率
ARK Investment Management LLC
12.08%
SoftBank Group Corp
6.81%
BlackRock Institutional Trust Company, N.A.
6.65%
Madrone Advisors, LLC
5.58%
The Vanguard Group, Inc.
5.33%
他の
63.55%
株主統計
株主統計
比率
ARK Investment Management LLC
12.08%
SoftBank Group Corp
6.81%
BlackRock Institutional Trust Company, N.A.
6.65%
Madrone Advisors, LLC
5.58%
The Vanguard Group, Inc.
5.33%
他の
63.55%
種類
株主統計
比率
Investment Advisor
43.81%
Investment Advisor/Hedge Fund
10.60%
Holding Company
6.81%
Individual Investor
1.17%
Corporation
1.17%
Hedge Fund
0.99%
Research Firm
0.88%
Bank and Trust
0.50%
Venture Capital
0.32%
他の
33.76%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
600
214.62M
71.52%
-110.62M
2025Q1
629
227.30M
75.82%
-104.21M
2024Q4
625
258.31M
94.32%
-61.55M
2024Q3
618
231.32M
84.94%
-85.30M
2024Q2
629
240.26M
88.29%
-64.03M
2024Q1
637
265.38M
97.57%
-38.04M
2023Q4
643
276.71M
103.53%
-9.49M
2023Q3
631
258.82M
103.48%
-18.47M
2023Q2
639
248.61M
99.68%
-37.06M
2023Q1
649
249.45M
101.17%
-6.40M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
ARK Investment Management LLC
36.48M
12.16%
+434.08K
+1.20%
Mar 31, 2025
SoftBank Group Corp
20.45M
6.82%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
20.44M
6.81%
-1.17M
-5.42%
Mar 31, 2025
Madrone Advisors, LLC
23.39M
7.8%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
16.21M
5.4%
+1.04M
+6.83%
Mar 31, 2025
Edmond de Rothschild Asset Management (France) S.A.
21.86M
7.28%
+508.70K
+2.38%
Mar 31, 2025
Amova Asset Management Co., Ltd.
9.57M
3.19%
-613.17K
-6.02%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.32M
2.11%
+54.32K
+0.87%
Mar 31, 2025
State Street Global Advisors (US)
6.38M
2.13%
-47.38K
-0.74%
Mar 31, 2025
Shimoda Holdings LLC
3.50M
1.17%
--
--
Dec 31, 2023
詳細を見る
関連ETF
銘柄名
比率
データなし
配当金
過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
KeyAI